Chronic Renal Failure Flashcards

1
Q

What are the two leading causes of end-stage renal

disease?

A

Diabetes mellitus and hypertension.
Stoelting RK, Hillier SC. Pharmacology and Physiology in
Anesthetic Practice. Philadelphia, PA: Lippincott Williams and
Wilkins; 2006: 341.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What percentage of the nephrons will be destroyed

before patients with ESRD become symptomatic?

A

90%
Hines RL, Marschall KE. Anesthesia & Co-Existing Diseases.
6th ed. Philadelphia, PA: Elsevier-Saunders; 2012: 341.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What electrolyte imbalances does chronic renal

failure cause?

A

Hyponatremia, hyperkalemia, hyperphosphatemia,
hypocalcemia, and metabolic acidosis.
Yao FF. Anesthesiology: Problem-Oriented Patient
Management. 7th ed. Philadelphia: Lippincott, Williams, and
Wilkins; 2012: 651.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the clinical signs of chronic renal

insufficiency?

A

Initially, nonspecific signs such as malaise and fatigue may be
present. Volume overload, electrolyte and acid-base
alterations, and decreased urine output are late signs of chronic
renal insufficiency.
Hines RL, Marschall KE. Anesthesia & Co-Existing Diseases.
6th ed. Philadelphia, PA: Elsevier-Saunders; 2012: 342-344.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the first substances that begin to
accumulate in the plasma as renal failure
progresses?

A

Urea and creatinine are the first substances to accumulate in
the plasma in patients with ESRD. They begin to elevate when
renal function drops to 50%.
Hines RL, Marschall KE. Anesthesia & Co-Existing Diseases.
6th ed. Philadelphia, PA: Elsevier-Saunders; 2012: 342.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

When during the progression of renal failure does
the serum potassium begin to rise? How does the
body try to compensate for this?

A

When the glomerular filtration reaches 10% of normal, serum
potassium begins to elevate. The kidneys compensate by
increasing blood flow through the remaining nephrons and by
excreting more potassium through the gastrointestinal tract.
Hines RL, Marschall KE. Anesthesia & Co-Existing Diseases.
6th ed. Philadelphia, PA: Elsevier-Saunders; 2012: 342.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What hematologic changes occur with ESRD?

A

Anemia is universal among patients with ESRD and is due to
chronic blood loss, hemolysis, uremic suppression of bone
marrow, iron and folate deficiency, and a decrease in the
production of erythropoetin.
Yao FF. Anesthesiology: Problem-Oriented Patient
Management. 7th ed. Philadelphia: Lippincott, Williams, and
Wilkins; 2012: 652.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How does chronic renal failure affect coagulation?

A

Patients with ESRD exhibit prolonged bleeding times due to
uremia despite normal platelet counts, prothrombin time, and
partial thromboplastin time. They may also exhibit a
predisposition to thromboembolism related to impaired
fibrinolysis, increased platelet aggregation, and altered protein
C and protein S activity.
Yao FF. Anesthesiology: Problem-Oriented Patient
Management. 6th ed. Philadelphia: Lippincott, Williams, and
Wilkins; 2008: 824.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the anesthesia considerations at induction

of anesthesia for patients with chronic renal failure?

A

Induction should proceed slowly using conventional agents
(thiopental, propofol, etomidate) to avoid excessive
hypotension. Regardless of the volume status of the patient
with ESRD, they respond as if they were hypovolemic. Uremia
can slow gastric emptying time, which can increase the risk for
gastric reflux.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What positioning concerns would you have for a

patient with chronic renal failure?

A

Poor nutritional status makes their skin extremely susceptible to
sloughing and bruising. Be sure to provide extra padding at
vulnerable areas such as the dialysis fistulas, elbows, knees,
and heels. Try to avoid tucking the arm with the fistula if the
patient undergoes dialysis so that it can be evaluated during the
procedure.
Stoelting RK, Dierdorf SF. Anesthesia & Co-Existing Diseases.
5th ed. New York, NY: Churchill-Livingston; 2008: 338.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is of extreme importance when performing
neuraxial anesthesia or placing invasive lines in
patients with chronic renal failure?

A

Aseptic technique should be adhered to strictly because these
patients are extremely susceptible to infection.
Stoelting RK, Dierdorf SF. Anesthesia & Co-Existing Diseases.
5th ed. New York, NY: Churchill-Livingston; 2008: 339.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Would you expect awake patients with chronic renal
failure to exhibit hyperventilation or hypoventilation
at rest? Why or why not?

A

They tend to exhibit hyperventilation. This may be due to
chronic metabolic acidosis and the increased predisposition to
pulmonary edema.
Barash PG, Cullen BF, Stoelting RK, Cahalan MK, Stock MC,
Ortega R. Clinical Anesthesia. 7th ed. Philadelphia, PA:
Lippincott Williams and Wilkins; 2013: 1411.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

A patient with chronic renal failure exhibits extreme
hyperkalemia. What are appropriate methods for
reducing the potassium level urgently?

A

Severe hyperkalemia can be life-threatening and must be
treated immediately. Administration of calcium chloride
stabilizes the heart against dangerous arrhythmias while other
methods of reducing the serum potassium are begun.
Administration of glucose and insulin, sodium bicarbonate
administration, hyperventilation, dialysis, and administration of
potassium-binding resins are all methods of reducing the serum
potassium level.
Butterworth JF, Mackey DC, Wasnick JD. Morgan & Mikhail’s
Clinical Anesthesiology. 5th ed. New York, NY: McGraw-Hill;
2013: 1129-1130.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Should patients on dialysis undergo treatment during

the perioperative period?

A

Yes. Patients who are on hemodialysis should be dialyzed
within 24 hours of surgery to minimize the chances of volume
overload, hyperkalemia, and uremic bleeding.
Hines RL, Marschall KE. Anesthesia & Co-Existing Diseases.
6th ed. Philadelphia, PA: Elsevier-Saunders; 2012: 346.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the most common cause of death in patients

receiving hemodialysis?

A

Cardiovascular events and infection
Hines RL, Marschall KE. Anesthesia & Co-Existing Diseases.
6th ed. Philadelphia, PA: Elsevier-Saunders; 2012: 345.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the most common adverse event in patients

receiving hemodialysis?

A

hypotension
Hines RL, Marschall KE. Anesthesia & Co-Existing Diseases.
6th ed. Philadelphia, PA: Elsevier-Saunders; 2012: 345

17
Q

What pathologic conditions are associated with

uremia?

A

Cardiac enlargement, ventricular hypertrophy, CHF, impaired
mental acuity, and immunocompromise.
Yao FF. Anesthesiology: Problem-Oriented Patient
Management. 7th ed. Philadelphia: Lippincott, Williams, and
Wilkins; 2012: 654-655

18
Q

How is osteodystrophy linked to chronic renal failure?

A

As the kidneys fail, there is an accumulation of phosphate. The
elevated phosphate levels lead to a decrease in serum calcium
levels. Hypocalcemia causes the release of parathyroid
hormone which causes bone demineralization to restore serum
calcium levels.
Hines RL, Marschall KE. Anesthesia & Co-Existing Diseases.
6th ed. Philadelphia, PA: Elsevier-Saunders; 2012: 342-343.

19
Q

Is succinylcholine contraindicated in patients with

chronic renal failure?

A

No. Patients with chronic renal failure do not exhibit
exaggerated hyperkalemic responses to succinylcholine. If the
preoperative potassium is in the high to high-normal range, you
should evaluate whether the increase in potassium due to
succinylcholine (0.5-1.0 mEq/L) might predispose the patient to
dysrhythmias.
Hines RL, Marschall KE. Anesthesia & Co-Existing Diseases.
6th ed. Philadelphia, PA: Elsevier-Saunders; 2012: 347.

20
Q

Why do patients with chronic renal failure require

smaller doses of thiopental?

A

Patients with chronic renal disease exhibit reduced plasma
protein binding of drugs. As a result, the free fraction of
thiopental is increased dramatically. The IV dose for thiopental
is generally half that given for patients with normal renal
function.
Barash PG, Cullen BF, Stoelting RK, Cahalan MK, Stock MC,
Ortega R. Clinical Anesthesia. 7th ed. Philadelphia, PA:
Lippincott Williams and Wilkins; 2013: 1411.

21
Q

How does the pharmacokinetic profile of propofol in
patients with ESRD compare to patients with normal
renal function? What about ketamine? Etomidate?

A

Propofol is rapidly metabolized by the liver and does not show
signs of prolonged duration of action in patients with ESRD.
Ketamine and etomidate do not undergo as extensive a degree
of protein binding as that seen with thiopental, but they do have
a slightly increased free fraction.
Barash PG, Cullen BF, Stoelting RK, Cahalan MK, Stock MC,
Ortega R. Clinical Anesthesia. 7th ed. Philadelphia, PA:
Lippincott Williams and Wilkins; 2013: 1411.

22
Q

Why is the duration of action of midazolam

prolonged in patients with renal disease?

A

Benzodiazepines are extensively protein bound. The reduced
protein binding in patients with renal disease results in an
increased free fraction of the drug. Also, 60-80% of midazolam
is excreted as an active metabolite. In renal disease, this
metabolite accumulates and can result in prolonged sedation.
Barash PG, Cullen BF, Stoelting RK, Cahalan MK, Stock MC,
Ortega R. Clinical Anesthesia. 7th ed. Philadelphia, PA:
Lippincott Williams and Wilkins; 2013: 1411.

23
Q

Which three muscle relaxants exhibit the least

degree of prolongation in patients with renal failure?

A

Only succinylcholine, atracurium, and cisatracurium do not rely
on renal excretion and have minimal if any prolongation of effect
in patients with renal disease. Laudanosine, the principal
metabolite of atracurium and cisatracurium, does rely on renal
excretion. It produces no neuromuscular relaxant effect, but
can produce CNS excitation if it accumulates. There are no
clinical data linking laudanosine with complications with ESRD
patients, but careful titration using a peripheral nerve stimulator
would be prudent.
Hines RL, Marschall KE. Anesthesia & Co-Existing Diseases.
6th ed. Philadelphia, PA: Elsevier-Saunders; 2012: 347.

24
Q

How does single-dose administration of morphine
compare to continuous infusion or repeated dosing
of morphine in patients with renal disease?

A

A single dose of morphine demonstrates no significant
prolongation of effect in patients with renal disease. With
repeated dosing or infusion, however, morphine’s active
metabolite, morphine-6 glucuronide, accumulates and can
result in prolonged narcosis.
Barash PG, Cullen BF, Stoelting RK, Cahalan MK, Stock MC,
Ortega R. Clinical Anesthesia. 7th ed. Philadelphia, PA:
Lippincott Williams and Wilkins; 2013: 1412.

25
Q

How are the pharmacokinetics of fentanyl and

remifentanil affected in patients with renal disease?

A

Fentanyl has no active metabolites, no alteration in its free
fraction, and is tolerated well in small, titrated doses in patients
with renal impairment. Remifentanil undergoes extensive
metabolism in the blood and tissue by esterases and is not
affected to any significant degree by renal disease.
Barash PG, Cullen BF, Stoelting RK, Cahalan MK, Stock MC,
Ortega R. Clinical Anesthesia. 7th ed. Philadelphia, PA:
Lippincott Williams and Wilkins; 2013: 1412.

26
Q

How is the duration of action of anticholinesterase

drugs affected by chronic renal failure?

A

Approximately 50% of neostigmine undergoes renal elimination
and 75% of edrophonium and pyridostigmine undergo renal
elimination. As a result, the elimination half-times of these
drugs is significantly prolonged by renal failure.
Hines RL, Marschall KE. Anesthesia & Co-Existing Diseases.
6th ed. Philadelphia, PA: Elsevier-Saunders; 2012: 348.